Before beginning HRT, ask when the treatment will be reviewed and what you should report sooner. The first prescription is the start of a care plan. A review gives you a chance to discuss whether the intended benefits are happening and whether the routine is workable.
Response varies by symptom, treatment and person. This article offers an appointment framework rather than a deadline for feeling better. A concerning new symptom should be reported when it occurs, even if the planned review is still several weeks away.
In this entry
Before starting: define the purpose
Write down the main reason for each prescribed medicine. That might be treatment of hot flashes or local vaginal symptoms, for example. Ask the clinician what change they would consider meaningful and how you will assess it together. If you cannot explain a medicine's purpose, ask before leaving the appointment.
Also clarify the route, schedule and contact details for questions. Use how to read an HRT prescription to organize the label information. Keep the plan somewhere you can find it without logging into several portals when a pharmacy calls.
In the early weeks: keep a small record
Choose a few observations that connect directly with your goals. For sleep disrupted by sweating, note the number of affected nights and a short description of the effect on the following day. For another concern, use an equally simple observation. You do not need to measure every symptom every day.
Record unwanted effects and practical problems separately. A patch that will not stay attached belongs in the account even if you are unsure whether it changed your symptoms. The patch-use checklist helps you provide useful details. Also mention missed treatment honestly; a review works best with an accurate picture of actual use.
Around the planned review: assess the pattern
NHS patient guidance says improvement may begin within days or weeks, while the fuller effect can take up to three months. It describes a review at roughly three months after starting or changing HRT. This is UK general guidance, included as a planning reference rather than a rule for every US care plan.
Ask your prescriber to set the timing appropriate for you. Some circumstances need earlier contact or closer monitoring. A provider's advertised billing interval should not determine when a medical problem is reviewed. Confirm whether an additional appointment is included or billed separately.
At the appointment: distinguish four questions
Describe whether the target symptoms improved, what unwanted effects occurred, whether you could follow the instructions and what remains unexplained. Those questions help avoid collapsing everything into a single judgment that HRT worked or failed.
The next step might involve continuing, reconsidering the route, investigating another cause or discussing a different treatment. That is a clinical decision. Do not add doses or another hormone product because you have reached an online timeline without the improvement you hoped for.
Between appointments: know the earlier-contact plan
Unexpected bleeding belongs in a direct report to the clinician, with its timing and amount. The bleeding checklist explains what information helps. Chest pain, sudden shortness of breath, stroke-like symptoms or feeling seriously unwell require emergency evaluation rather than a routine message.
If you have had a hysterectomy, make sure the clinician has the relevant surgical details. New health conditions and other prescription changes can also affect the review, even when they seem unrelated to menopause.
Leave with the next decision recorded
Write a short summary of what you and the clinician agreed, who will arrange any tests and when you should hear back. If the prescription changes, confirm which previous instructions are replaced. Ask when the next follow-up will happen and how refills fit into that schedule.
When comparing Elektra, Elevate MD or another service, ask about this process before enrollment. The care-plan guide helps connect the follow-up you need with what the fee actually includes.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.